Conference Coverage: EHA 2022 – Focus on Lymphoma
Lymphoma-specific discussions on latest research updates, therapeutic advances, and their application in clinical decision-making.
Brad S. Kahl, MD
Washington University School of Medicine, St. Louis, MO, USA
- Advances in DLBCL/Aggressive B-Cell Lymphoma
- Advances in CAR T
- Advances in FL
- Advances in MCL and MZL
- Evolving Use of BTK Inhibitors in CLL
- Role of Fixed-Duration and MRD-Guided Strategies in CLL
Complete the form below to receive additional information.